Generation Bio Co

NASDAQ:GBIO   4:00:00 PM EDT
4.07
+0.37 (+10.00%)
4:20:25 PM EDT: $4.07 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)270.56M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$1.36 Million
Adjusted EPS-$0.42
See more estimates
10-Day MA$3.39
50-Day MA$2.45
200-Day MA$3.10
See more pivots

Generation Bio Co Stock, NASDAQ:GBIO

301 Binney Street, Cambridge, Massachusetts 02142
United States of America
Phone: +1.617.655.7500
Number of Employees: 174

Description

Generation Bio Co. is a genetic medicine company, which focuses on creating a new class of gene therapy to provide durable and redosable treatment for patients suffering from both rare and prevalent diseases. Its non-viral platform incorporates a proprietary high-capacity DNA construct called closed-ended DNA, or ceDNA, a novel cell-targeted lipid nanoparticle delivery system, or ctLNP, and an established, scalable capsid-free manufacturing process. The company was founded by Mark D. Angelino, Jason P. Rhodes, and Robert M. Kotin in 2016 and is headquartered in Cambridge, MA.